Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors | MicrobiomeTrials← Back to trialsNCT07645742
Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07Est. Completion: 2029-02
Enrollment target: 90 participants Other microbiome trials you might be interested in
MelanomaAdvanced MelanomaMetastatic MelanomaUnresectable Melanoma
CMP-001-011 is a Phase 2/3 study of CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monot…
Phoenix, United StatesCompleted Jul 22, 2024
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell CarcinomaCervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Cervical Squamous Cell Carcinoma
Stage IB2 Cervical Cancer AJCC v6 and v7
Stage II Cervical Cancer AJCC v7
Stage II Vaginal Cancer AJCC v6 and v7
Stage IIA Cervical Cancer AJCC v7
Stage IIB Cervical Cancer AJCC v6 and v7
Stage III Vaginal Cancer AJCC v6 and v7
Stage IIIB Cervical Cancer AJCC v6 and v7
Stage IV Vaginal Cancer AJCC v6 and v7
Stage IVA Cervical Cancer AJCC v6 and v7
Stage IVA Vaginal Cancer AJCC v6 and v7
Unresectable Vaginal Carcinoma
Vaginal Adenocarcinoma
Vaginal Adenosquamous Carcinoma
Vaginal Carcinoma
Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
This randomized phase III trial studies radiation therapy and cisplatin with triapine to see how well they work compared…
Birmingham, United StatesEst. completion Jan 26, 2023
DeliriumLocally Advanced Malignant NeoplasmMetastatic Malignant NeoplasmRecurrent Malignant Neoplasm
This phase II/IIII trial studies how well haloperidol and lorazepam work in controlling symptoms of persistent agitated …
Houston, United StatesEst. completion Dec 31, 2028